Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jan. 31, 2022	Apr. 30, 2021
Current Assets:
Cash and cash equivalents	$ 4,697	$ 5,206
Restricted cash	805	525
Receivables, less allowance; $426; $636, on each respective date	35,053	32,882
Inventories	19,947	16,517
Income tax receivable	638	955
Prepaid expenses and other current assets	7,780	4,372
Total Current Assets	68,920	60,457
Property, plant and equipment, at cost	60,269	58,804
Accumulated depreciation	(44,924)	(42,822)
Net Property, Plant and Equipment	15,345	15,982
Right of use assets	8,006	9,279
Other assets	3,415	3,666
Total Assets	95,686	89,384
Current Liabilities:
Short-term borrowings	8,962	6,828
Current portion of financing lease liability	131	21
Current portion of operating lease liabilities	1,355	1,348
Accounts payable	27,415	16,780
Employee compensation and amounts withheld	4,930	4,726
Deferred revenue	3,104	3,123
Other accrued expenses	1,611	1,355
Total Current Liabilities	47,508	34,181
Long-term portion of financing lease liability	198	91
Long-term portion of operating lease liabilities	6,605	7,860
Accrued pension and deferred compensation costs	4,381	4,652
Deferred income taxes	411	307
Other non-current liabilities	403	806
Total Liabilities	59,506	47,897
Commitments and Contingencies
Stockholders' Equity:
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,793 shares; 2,766 shares; – Outstanding – 2,790 shares; 2,763 shares, on each respective date	6,983	6,915
Additional paid-in-capital	4,216	3,807
Retained earnings	28,385	34,149
Accumulated other comprehensive loss	(3,684)	(3,577)
Common stock in treasury, at cost, 3 shares, on each respective date	(53)	(53)
Total Kewaunee Scientific Corporation Stockholders' Equity	35,847	41,241
Non-controlling interest	333	246
Total Stockholders' Equity	36,180	41,487
Total Liabilities and Stockholders' Equity	$ 95,686	$ 89,384